July 22, 2024

Zimmer Biomet Opens Commercial Office in Dubai Following Sustained Growth in Middle East

 Zimmer Biomet Opens Commercial Office in Dubai Following Sustained Growth in Middle East

DUBAI, United Arab Emirates, January 27, 2022— Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health, has opened a new commercial office in Dubai, United Arab Emirates.

The decision follows years of growing sales of Zimmer Biomet’s advanced technologies, surgical robotics and implants to hospitals and clinics in the Middle East, North Africa and Turkey (MENAT).

Zimmer Biomet’s new office was opened in the same week that the company showcased its industry-leading technologies during the Arab Health 2022 tradeshow at the Dubai World Trade Centre.

“This region has one of the most highly enabled digital populations. We are partnering with hospitals, clinics and health authorities to help them to benefit from Zimmer Biomet’s technology and data to improve efficiency and patient outcomes,” said Erik Antos, Vice President of Emerging Markets, Zimmer Biomet.

The Dubai office will be led by Farah Hamdan, who joined Zimmer Biomet in January 2022 as General Manager for MENAT. Farah brings more than 17 years of experience in healthcare and is responsible for partnering with customers to enhance the quality of care they provide to patients.

“We’re increasing our reach and investment across the region. This means we can partner with even more customers to meet the increasing expectations of patients for personal and connected digital experiences and deliver data-driven insights so they can also improve their efficiency,” Hamdan said.

The opening of Zimmer Biomet’s Dubai office demonstrates the company’s commitment to helping customers maintain momentum during a transformative period in healthcare, and to alleviating pain and improving quality of life for people around the world.

The MENAT region is an important customer base for Zimmer Biomet, with a significant uptick in interest and adoption of its healthcare technologies over the past 10 years.